[
    [
        {
            "time": "",
            "original_text": "上药控股牵手住友制药 探索处方药联合营销新模式",
            "features": {
                "keywords": [
                    "上药控股",
                    "住友制药",
                    "处方药",
                    "联合营销",
                    "新模式"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "上药控股牵手住莫制药 探索处方药联合营销新模式",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "明星基金年化收益不到4%！在基金圈追星，这件事不靠谱",
            "features": {
                "keywords": [
                    "明星基金",
                    "年化收益",
                    "基金圈",
                    "追星",
                    "不靠谱"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "明星基金年化收益不到4%！在基金圈追星，这件事不靠谱",
                "Correlation": 3,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药行业重大转折，2021政策趋势来了",
            "features": {
                "keywords": [
                    "医药行业",
                    "重大转折",
                    "政策",
                    "趋势",
                    "2021"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业重大转折，2021政策趋势来了",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "曹名长管理的中欧恒利年化收益不到4%: 在基金圈追星 这事儿不靠谱",
            "features": {
                "keywords": [
                    "曹名长",
                    "中欧恒利",
                    "年化收益",
                    "基金圈",
                    "追星",
                    "不靠谱"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "曹名长管理的中欧恒利年化收益不到4%: 在基金圈追星 这事儿不靠谱",
                "Correlation": 4,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "中华药业使用化妆品禁用原料遭立案 为上海医药子公司",
            "features": {
                "keywords": [
                    "中华药业",
                    "化妆品禁用原料",
                    "立案",
                    "上海医药",
                    "子公司"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "中华药业使用化妆品禁用原料遭立案 为上海医药子公司",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "天宝药业违规遭重庆药监局警告 为上海医药旗下企业 其他违规处罚",
            "features": {
                "keywords": [
                    "天宝药业",
                    "违规",
                    "重庆药监局",
                    "警告",
                    "上海医药",
                    "旗下企业",
                    "处罚"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "天宝药业违规遭重庆药监局警告 为上海医药旗下企业 其他违规处罚",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "上海医药、瑞康医药高管离职 董监高成员变化",
            "features": {
                "keywords": [
                    "上海医药",
                    "瑞康医药",
                    "高管离职",
                    "董监高",
                    "成员变化"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海医药、瑞康医药高管离职 董监高成员变化",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "中信证券：从A/H折溢价看港股的估值洼地和稀缺性建议关注两大主线",
            "features": {
                "keywords": [
                    "中信证券",
                    "A/H折溢价",
                    "港股",
                    "估值洼地",
                    "稀缺性",
                    "关注",
                    "主线"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "证券",
                    "港股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "中信证券：从A/H折溢价看港股的估值洼地和稀缺性建议关注两大主线",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "权益投资乘风起，银行理财为A股注“活水”",
            "features": {
                "keywords": [
                    "权益投资",
                    "银行理财",
                    "A股",
                    "活水"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "银行",
                    "A股"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "权益投资乘风起，银行理财为A股注“活水”",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]